Budget Amount *help |
¥19,500,000 (Direct Cost: ¥15,000,000、Indirect Cost: ¥4,500,000)
Fiscal Year 2014: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2013: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2012: ¥7,280,000 (Direct Cost: ¥5,600,000、Indirect Cost: ¥1,680,000)
|
Outline of Final Research Achievements |
Several kainoid-type analogs were designed and synthesized for the purpose of identifying a novel receptor involved in the induction and maintenance of allodynia, a major symptom of neuropathic pain. Efficient synthetic methods to selectively modify the individual substituents attached to the pyrrolidine-ring skeleton of kainoids were established, making it possible to easily prepare kainoid analogs with a variety of substituents. Evaluation of the synthetic kainoids for allodynia-inducing/suppressing activity and binding affinity for glutamate receptors specified some promising analogs as biochemical tools. The existence of a novel activation mechanism of kainate receptor was also suggested.
|